Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Working Capital Changes (2016 - 2025)

Palisade Bio (PALI) has disclosed Other Working Capital Changes for 16 consecutive years, with $603000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 412.44% to $603000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $958000.0, a 181.88% increase, with the full-year FY2024 number at -$121000.0, up 82.84% from a year prior.
  • Other Working Capital Changes was $603000.0 for Q3 2025 at Palisade Bio, up from $1000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $603000.0 in Q3 2025 to a low of -$628000.0 in Q4 2023.
  • A 5-year average of -$5937.5 and a median of -$43000.0 in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 3240.0% in 2023, then skyrocketed 412.44% in 2025.
  • Palisade Bio's Other Working Capital Changes stood at -$39000.0 in 2021, then skyrocketed by 151.28% to $20000.0 in 2022, then plummeted by 3240.0% to -$628000.0 in 2023, then surged by 167.04% to $421000.0 in 2024, then soared by 43.23% to $603000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Working Capital Changes are $603000.0 (Q3 2025), $1000.0 (Q2 2025), and -$67000.0 (Q1 2025).